Companion Animal Diagnostic Services Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)
The global Companion Animal Diagnostic Services Market size is forecast to increase from $6.96 Billion in 2026 to $13.77 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.
The Companion Animal Diagnostic Services market report provides detailed analysis and outlook of Companion Animal Diagnostic Services segments including By Service Type: (Clinical Pathology, Imaging Services, Molecular Diagnostics, Toxicology & Microbiology, Histopathology), By Animal Type: (Dogs, Cats, Equine, Others), By End-User: (Veterinary Hospitals & Clinics, Reference Laboratories, Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Companion Animal Diagnostic Services Industry Overview
Advanced Diagnostic Technologies Are Enhancing Veterinary Care
The companion animal diagnostic services industry is rapidly evolving as veterinary clinics adopt sophisticated diagnostic technologies capable of delivering faster and more comprehensive clinical insights. Rising demand for preventive care, chronic disease management, and personalized veterinary medicine is accelerating the use of in-clinic analyzers, imaging systems, molecular diagnostics, and biomarker-based testing. Veterinary providers increasingly seek integrated platforms that support rapid decision-making while minimizing turnaround times. This shift is helping improve diagnostic accuracy and enabling earlier intervention for a wide range of companion animal health conditions.
IDEXX Expands Diagnostic Menus and In-Clinic Testing Capabilities
IDEXX Laboratories continues to strengthen its position through expansion of cloud-connected diagnostic ecosystems and advanced testing platforms. The company reported placement of 1,100 IDEXX inVue Dx™ imaging instruments while also expanding its Fecal Dx® platform with a molecular assay capable of detecting Taeniid Tapeworms. In addition, IDEXX integrated Symmetric Dimethylarginine (SDMA), an important kidney function biomarker, directly into its Catalyst™ chemistry panels. These enhancements demonstrate the growing industry focus on combining imaging, molecular diagnostics, and biomarker testing within streamlined in-clinic workflows to support more efficient veterinary care delivery.
Precision Medicine and Point-of-Care Testing Driving Innovation
Precision diagnostics is becoming a major growth area within companion animal healthcare. Zoetis announced plans to acquire Neogen Corporation's veterinary genomic technologies and data solutions business, a move designed to integrate predictive genomics with diagnostic testing and create highly individualized animal health profiles. At the same time, reference laboratory networks have expanded production of advanced microfluidic assay cassettes to address supply limitations affecting veterinary diagnostic testing. These microfluidic ELISA platforms enable clinics to perform multi-biomarker pancreatic and thyroid screenings directly on point-of-care systems, eliminating delays associated with traditional mail-in laboratory testing and supporting faster clinical decision-making.
Companion Animal Diagnostic Services Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Companion Animal Diagnostic Services market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- IDEXX Laboratories, Inc., Zoetis Inc. (Zoetis Reference Laboratories), Antech Diagnostics, Inc. (Mars, Incorporated), FUJIFILM Corporation (FUJIFILM VET Systems), Thermo Fisher Scientific Inc., bioMérieux S.A., Virbac S.A., Agrolabo S.p.A., Esaote S.p.A., Embark Veterinary, Inc.. The Companion Animal Diagnostic Services market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Companion Animal Diagnostic Services industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
-
Growth Companion Animal Diagnostic Services Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
-
Market Trends, Drivers, Potential Opportunities, and Challenges faced by Companion Animal Diagnostic Services companies
-
Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
-
Detailed SWOT Analysis of global and regional Companion Animal Diagnostic Services markets
-
Competitive analysis including business description, product analysis, and financial profiles
-
Key country specific analysis detailing key factors shaping the short-term and long-term outlook
-
Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Companion Animal Diagnostic Services Market Competitive Benchmarking and Company Analysis
Leading companies in Companion Animal Diagnostic Services industry include- IDEXX Laboratories, Inc., Zoetis Inc. (Zoetis Reference Laboratories), Antech Diagnostics, Inc. (Mars, Incorporated), FUJIFILM Corporation (FUJIFILM VET Systems), Thermo Fisher Scientific Inc., bioMérieux S.A., Virbac S.A., Agrolabo S.p.A., Esaote S.p.A., Embark Veterinary, Inc.. The Companion Animal Diagnostic Services market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Companion Animal Diagnostic Services Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Companion Animal Diagnostic Services market remains one of the strongest-performing segments in the country.
The US Companion Animal Diagnostic Services Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Companion Animal Diagnostic Services market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Companion Animal Diagnostic Services industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Companion Animal Diagnostic Services markets
Canada's strong Companion Animal Diagnostic Services sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Companion Animal Diagnostic Services market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Companion Animal Diagnostic Services Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Companion Animal Diagnostic Services market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Companion Animal Diagnostic Services population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Companion Animal Diagnostic Services industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Companion Animal Diagnostic Services market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Companion Animal Diagnostic Services sales through 2034
France Companion Animal Diagnostic Services companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Companion Animal Diagnostic Services Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Companion Animal Diagnostic Services distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Companion Animal Diagnostic Services Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Companion Animal Diagnostic Services market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Companion Animal Diagnostic Services industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Companion Animal Diagnostic Services industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Companion Animal Diagnostic Services Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Companion Animal Diagnostic Services market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Companion Animal Diagnostic Services market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Companion Animal Diagnostic Services Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Companion Animal Diagnostic Services Market Segmentation
By Service Type:
Clinical Pathology
Imaging Services
Molecular Diagnostics
Toxicology & Microbiology
Histopathology
By Animal Type:
Dogs
Cats
Equine
Others
By End-User:
Veterinary Hospitals & Clinics
Reference Laboratories
Research Institutes
Top Companies in Companion Animal Diagnostic Services Industry
IDEXX Laboratories, Inc.
Zoetis Inc. (Zoetis Reference Laboratories)
Antech Diagnostics, Inc. (Mars, Incorporated)
FUJIFILM Corporation (FUJIFILM VET Systems)
Thermo Fisher Scientific Inc.
bioMérieux S.A.
Virbac S.A.
Agrolabo S.p.A.
Esaote S.p.A.
Embark Veterinary, Inc.
Countries Included
-
North America- US, Canada, Mexico
-
Europe- Germany, France, UK, Spain, Italy, Nordics, Others
-
Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
-
Latin America- Brazil, Argentina, Others
-
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Latest Market Updates In Healthcare
Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.
By Service Type:
Clinical Pathology
Imaging Services
Molecular Diagnostics
Toxicology & Microbiology
Histopathology
By Animal Type:
Dogs
Cats
Equine
Others
By End-User:
Veterinary Hospitals & Clinics
Reference Laboratories
Research Institutes